California Public Employees Retirement System
LAB icon

California Public Employees Retirement System’s Standard BioTools LAB Stock Holding History

California Public Employees Retirement System’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-143,200
Closed -$647K – 2272
2021
Q1 		$647K Sell
143,200
-13,407
-9% -$73.6K ﹤0.01% 2797
2020
Q4 		$940K Sell
156,607
-7,496
-5% -$49.2K ﹤0.01% 2518
2020
Q3 		$1.22M Buy
164,103
+7,896
+5% +$54.5K ﹤0.01% 2133
2020
Q2 		$626K Buy
156,207
+20,729
+15% +$72.2K ﹤0.01% 2543
2020
Q1 		$344K Hold
135,478
– – ﹤0.01% 2589
2019
Q4 		$471K Buy
135,478
+12,500
+10% +$44K ﹤0.01% 2767
2019
Q3 		$569K Buy
122,978
+11,667
+10% +$91.9K ﹤0.01% 2515
2019
Q2 		$1.37M Buy
111,311
+50,405
+83% +$642K ﹤0.01% 1952
2019
Q1 		$809K Buy
60,906
+6,506
+12% +$68.6K ﹤0.01% 2336
2018
Q4 		$469K Hold
54,400
– – ﹤0.01% 2578
2018
Q3 		$407K Hold
54,400
– – ﹤0.01% 2762
2018
Q2 		$324K Hold
54,400
– – ﹤0.01% 2812
2018
Q1 		$318K Hold
54,400
– – ﹤0.01% 2821
2017
Q4 		$320K Hold
54,400
– – ﹤0.01% 2826
2017
Q3 		$274K Hold
54,400
– – ﹤0.01% 2901
2017
Q2 		$220K Hold
54,400
– – ﹤0.01% 2991
2017
Q1 		$310K Sell
54,400
-2,400
-4% -$15.2K ﹤0.01% 2860
2016
Q4 		$414K Hold
56,800
– – ﹤0.01% 2771
2016
Q3 		$455K Sell
56,800
-4,100
-7% -$37.7K ﹤0.01% 2763
2016
Q2 		$550K Sell
60,900
-1,900
-3% -$17.9K ﹤0.01% 2679
2016
Q1 		$507K Sell
62,800
-3,900
-6% -$28.1K ﹤0.01% 2722
2015
Q4 		$721K Hold
66,700
– – ﹤0.01% 2594
2015
Q3 		$541K Sell
66,700
-2,300
-3% -$36.2K ﹤0.01% 2743
2015
Q2 		$1.67M Buy
+69,000
New +$2.18M ﹤0.01% 2180
2014
Q2 		– Sell
-22,289
Closed -$780K – 3802
2014
Q1 		$780K Sell
22,289
-16,923
-43% -$745K ﹤0.01% 2688
2013
Q4 		$1.52M Buy
39,212
+38,112
+3,465% +$1.12M ﹤0.01% 2292
2013
Q3 		$24K Hold
1,100
– – ﹤0.01% 3708
2013
Q2 		$19K Buy
+1,100
New +$19.3K ﹤0.01% 3746

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

California Public Employees Retirement System's LAB Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Standard BioTools (LAB) in Q2 2021, closing a stake of 143,200 shares — an estimated $647K sold.

California Public Employees Retirement System first reported a position in LAB in Q2 2013 and held it in 28 quarters. The position peaked at $1.67M in Q2 2015. 113 funds tracked by Wall St. Rank hold LAB as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Standard BioTools position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 143,200 Standard BioTools shares in Q2 2021, an estimated $647K.
  • California Public Employees Retirement System first reported a position in Standard BioTools in Q2 2013 and held it in 28 quarters.
  • California Public Employees Retirement System's Standard BioTools position peaked at $1.67M in Q2 2015.
  • 113 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.